To investigate the viral genetic variation across the HPV16 genome potentially induced by human APOBEC3 cytidine deaminases and other mutational processes (signatures) and evaluate how these variants contribute to infection outcome (i.e., viral clearance or carcinogenesis), we analyze HPV16 whole-genome sequence data from 5328 case–control samples. This evidence concerns the gene CDA and infection.